These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32603780)

  • 1. Follow-up imaging after left atrial appendage closure.
    Kuroki K; Doshi SK; Whang W; Vanderzee S; Ducharme CB; Enomoto Y; Hanon S; Koruth JS; Miller MA; Choudry S; Sofi A; Langan N; Ellsworth B; Dukkipati SR; Reddy VY
    Heart Rhythm; 2020 Nov; 17(11):1848-1855. PubMed ID: 32603780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial appendage closure device implantation in patients at very high risk for stroke.
    Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
    Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
    Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transesophageal echocardiographic diagnosis of a WATCHMAN left atrial appendage closure device thrombus 10 years following implantation.
    Shamim S; Magalski A; Chhatriwalla AK; Allen KB; Huber KC; Main ML
    Echocardiography; 2017 Jan; 34(1):128-130. PubMed ID: 27862233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study.
    Mohanty S; Gianni C; Trivedi C; Gadiyaram V; Della Rocca DG; MacDonald B; Horton R; Al-Ahmad A; Gibson DN; Price M; Krumerman AK; Palma EC; Di Biase L; Lakkireddy D; Natale A
    Heart Rhythm; 2020 Feb; 17(2):175-181. PubMed ID: 31400519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography.
    Korsholm K; Jensen JM; Nørgaard BL; Nielsen-Kudsk JE
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008112. PubMed ID: 31514523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracardiac echocardiography-guided implantation of the Watchman FLX left atrial appendage closure device.
    Turagam MK; Neuzil P; Petru J; Hala P; Mraz T; Baroch J; Lekesova V; Prokopova M; Dukkipati SR; Reddy VY
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):717-725. PubMed ID: 33533089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracardiac versus transesophageal echocardiography for left atrial appendage occlusion with watchman.
    Frangieh AH; Alibegovic J; Templin C; Gaemperli O; Obeid S; Manka R; Holy EW; Maier W; Lüscher TF; Binder RK
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):331-338. PubMed ID: 27649848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed endothelialization of watchman device identified with cardiac CT.
    Sivasambu B; Arbab-Zadeh A; Hays A; Calkins H; Berger RD
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1319-1324. PubMed ID: 31257658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
    Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: Procedural and cost considerations.
    Hemam ME; Kuroki K; Schurmann PA; Dave AS; Rodríguez DA; Sáenz LC; Reddy VY; Valderrábano M
    Heart Rhythm; 2019 Mar; 16(3):334-342. PubMed ID: 30827462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cardiac computed tomography angiography and transoesophageal echocardiography for device surveillance after left atrial appendage closure.
    Qamar SR; Jalal S; Nicolaou S; Tsang M; Gilhofer T; Saw J
    EuroIntervention; 2019 Oct; 15(8):663-670. PubMed ID: 31217149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.